Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer In response to: Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions published by Di Maria Jiang et al. Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5

• Published in: Current oncology reports Vol. 23; no. 2; p. 18
• Main Authors: Böhmer, Dirk, Grün, Arne
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.02.2021
• Subjects: Chemotherapy, Adjuvant; Cystectomy; Humans; Letter to the Editor; Medicine; Medicine & Public Health; Muscles; Neoadjuvant Therapy; Oncology; Urinary Bladder Neoplasms - drug therapy; Trimodality treatment; Neoadjuvant chemotherapy; Bladder cancer

We comment on the paper of Di Maria Jiang et al. published in Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5 . We disagree on a major recommendation of the authors because of lacking evidence. This response is considered to be important for readers of Current Oncology Repor...